References
- van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;339:b2921.
- Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.
- Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404.
- Sitruk-Ware R, Nath A. The use of newer progestins for contraception. Contraception 2010;82:410–7.
- Sitruk-Ware R, Nath A. Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Pract Res Clin Endocrinol Metab 2013;27:13–24.
- Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005;112:2735–52.
- Endrikat J, Sandri M, Gerlinger C, et al. A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight. Eur J Contracept Reprod Health Care 2007;12:220–8.
- Maloney JM, Dietze P Jr, Watson D, et al. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial. Obstet Gynecol 2008;112:773–81.
- Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2008;4:CD003987.
- de Morais TL, Giribela C, Nisenbaum MG, et al. Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age. Eur J Obstet Gynecol Reprod Biol 2014;182:113–7.
- Cagnacci A, Ferrari S, Napolitano A, et al. Combined oral contraceptive containing drospirenone does not modify 24 h ambulatory blood pressure but increases heart rate in healthy young women: prospective study. Contraception 2013;88:413–7.
- Li M, Wang A, Hu L, et al. Effects of estradiol-drospirenone on menopausal symptoms, lipids and bone turnover in Chinese women. Climacteric 2015;18:214–8.
- Jairajpuri ZS, Rana S, Jetley S. Atypical uterine bleeding – histopathological audit of endometrium - a study of 638 cases. Al Ameen J Med Sci 2013;6:21–8.